Pacific Biosciences of California, Inc.
PACB
$1.33
$0.064.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.14% | -3.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.14% | -3.33% | |||
| Cost of Revenue | 80.80% | -10.42% | |||
| Gross Profit | -73.02% | 8.52% | |||
| SG&A Expenses | 14.96% | -14.03% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 35.56% | -8.69% | |||
| Operating Income | -54.80% | 13.44% | |||
| Income Before Tax | -6.78% | 10.21% | |||
| Income Tax Expenses | -47.26% | 994.29% | |||
| Earnings from Continuing Operations | -6.24% | 9.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.24% | 9.37% | |||
| EBIT | -54.80% | 13.44% | |||
| EBITDA | -59.42% | 14.17% | |||
| EPS Basic | -5.86% | 9.59% | |||
| Normalized Basic EPS | -46.61% | 10.44% | |||
| EPS Diluted | -2.85% | 7.14% | |||
| Normalized Diluted EPS | -46.61% | 10.44% | |||
| Average Basic Shares Outstanding | 0.35% | 0.23% | |||
| Average Diluted Shares Outstanding | 0.35% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||